Staged Nipple Delay Procedure Expands Candidacy for Nipple-Sparing Mastectomy.

Breast cancer Nipple delay Nipple-areolar complex necrosis Nipple-sparing mastectomy Skin-flap necrosis Surgical outcome

Journal

Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840

Informations de publication

Date de publication:
14 Oct 2024
Historique:
received: 07 06 2024
accepted: 23 09 2024
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 14 10 2024
Statut: aheadofprint

Résumé

Nipple delay (ND) is a staged procedure that improves nipple-areolar complex (NAC) viability in nipple-sparing mastectomy (NSM) patients who are high-risk for NAC or skin-flap necrosis. This study compared postoperative outcomes and risk factors between patients treated with ND-NSM and NSM alone. Patient demographics, risk factors for NAC or skin-flap necrosis, tumor characteristics, and operative outcomes were compared between ND-NSM and NSM groups from 2009 to 2023. Univariate and multivariate analyses were performed to identify significant variables associated with NAC or skin-flap necrosis. Overall, 71 ND-NSM patients and 537 NSM patients were compared. ND-NSM patients had larger breasts (p < 0.01), body mass index ≥ 30 (p = 0.01), prior breast/chest wall radiation (XRT) [p < 0.01], prior breast operations (p < 0.01), less axillary surgery (p < 0.01), more autologous tissue reconstruction over implant-based reconstruction compared with NSM patients (p = 0.02), and more prophylaxis (p < 0.01). There were no statistically significant differences between groups in regard to infection, skin-flap necrosis, NAC necrosis, seromas, and hematomas. No patients in the ND-NSM group had NAC necrosis and 1 patient had skin-flap necrosis, compared with 17 and 13 patients in the NSM group, respectively (p = 0.24). On univariate analysis, prior XRT was associated with increased risk for skin-flap necrosis (p = 0.02). Multivariate analysis showed XRT was associated with skin-flap necrosis (p = 0.02) and any necrosis (p = 0.01). Breast size was associated with NAC or skin-flap necrosis (p = 0.04). Larger breasts and XRT were risk factors for NAC or skin-flap necrosis; however, despite having more risk factors, ND-NSM patients had very low rates of necrosis. Notably, no nipples were lost. A shared decision should be made with patients regarding the risks and benefits of ND-NSM.

Sections du résumé

BACKGROUND BACKGROUND
Nipple delay (ND) is a staged procedure that improves nipple-areolar complex (NAC) viability in nipple-sparing mastectomy (NSM) patients who are high-risk for NAC or skin-flap necrosis. This study compared postoperative outcomes and risk factors between patients treated with ND-NSM and NSM alone.
METHODS METHODS
Patient demographics, risk factors for NAC or skin-flap necrosis, tumor characteristics, and operative outcomes were compared between ND-NSM and NSM groups from 2009 to 2023. Univariate and multivariate analyses were performed to identify significant variables associated with NAC or skin-flap necrosis.
RESULTS RESULTS
Overall, 71 ND-NSM patients and 537 NSM patients were compared. ND-NSM patients had larger breasts (p < 0.01), body mass index ≥ 30 (p = 0.01), prior breast/chest wall radiation (XRT) [p < 0.01], prior breast operations (p < 0.01), less axillary surgery (p < 0.01), more autologous tissue reconstruction over implant-based reconstruction compared with NSM patients (p = 0.02), and more prophylaxis (p < 0.01). There were no statistically significant differences between groups in regard to infection, skin-flap necrosis, NAC necrosis, seromas, and hematomas. No patients in the ND-NSM group had NAC necrosis and 1 patient had skin-flap necrosis, compared with 17 and 13 patients in the NSM group, respectively (p = 0.24). On univariate analysis, prior XRT was associated with increased risk for skin-flap necrosis (p = 0.02). Multivariate analysis showed XRT was associated with skin-flap necrosis (p = 0.02) and any necrosis (p = 0.01). Breast size was associated with NAC or skin-flap necrosis (p = 0.04).
CONCLUSION CONCLUSIONS
Larger breasts and XRT were risk factors for NAC or skin-flap necrosis; however, despite having more risk factors, ND-NSM patients had very low rates of necrosis. Notably, no nipples were lost. A shared decision should be made with patients regarding the risks and benefits of ND-NSM.

Identifiants

pubmed: 39402318
doi: 10.1245/s10434-024-16329-y
pii: 10.1245/s10434-024-16329-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Nahabedian MY, Tsangaris TN. Breast reconstruction following subcutaneous mastectomy for cancer: a critical appraisal of the nipple-areola complex. Plast Reconstr Surg. 2006;117:1083–90.
doi: 10.1097/01.prs.0000202103.78284.97 pubmed: 16582769
Metere A, Fabiani E, Lonardo MT, Giannotti D, Pace D, Giacomelli L. Nipple-sparing mastectomy long-term outcomes: early and late complications. Medicina (Kaunas). 2020;56(4):166. https://doi.org/10.3390/medicina56040166 .
doi: 10.3390/medicina56040166 pubmed: 32276470 pmcid: 7230840
Co M, Chiu R, Chiu TM, Chong YC, Lau S, Lee YH, et al. Nipple-sparing mastectomy and its application on BRCA gene mutation carrier. Clin Breast Cancer. 2017;17(8):581–4. https://doi.org/10.1016/j.clbc.2017.02.001 .
doi: 10.1016/j.clbc.2017.02.001 pubmed: 28428099
Stanek K, Zimovjanova M, Suk P, Jonas F, Zimovjanova A, Molitor M, et al. Bilateral prophylactic nipple-sparing mastectomy: analysis of the risk-reducing effect in BRCA1/2 mutation carriers. Aesthetic Plast Surg. 2022;46(2):706–11. https://doi.org/10.1007/s00266-021-02506-x .
doi: 10.1007/s00266-021-02506-x pubmed: 34342702
Rocco N, Montagna G, Criscitiello C, Nava MB, Privitera F, Taher W, et al. Nipple sparing mastectomy as a risk-reducing procedure for BRCA-mutated patients. Genes (Basel). 2021;12(2):253. https://doi.org/10.3390/genes12020253 .
doi: 10.3390/genes12020253 pubmed: 33578759 pmcid: 7916475
Algaithy ZK, Petit JY, Lohsiriwat V, et al. Nipple sparing mastectomy: Can we predict the factors predisposing to necrosis? Eur J Surg Oncol. 2012;38:125–9.
doi: 10.1016/j.ejso.2011.10.007 pubmed: 22056645
Jensen JA, Orringer JS, Giuliano AE. Nipple-sparing mastectomy in 99 patients with a mean follow-up of 5 years. Ann Surg Oncol. 2011;18:1665–70.
doi: 10.1245/s10434-010-1475-4 pubmed: 21174155
Karian LS, Therattil PJ, Wey PD, et al. Delay techniques for nipple-sparing mastectomy: a systematic review. J Plast Reconstr Aesthet Surg. 2017;70:236–42.
doi: 10.1016/j.bjps.2016.11.012 pubmed: 28040452
Houvenaeghel G, Cohen M, Dammacco MA, D’Halluin F, Regis C, Gutowski M, et al. Prophylactic nipple-sparing mastectomy with immediate breast reconstruction: results of a French prospective trial. Br J Surg. 2021;108:296–301.
doi: 10.1093/bjs/znaa082 pubmed: 33793719
Agha RA, Al Omran Y, Wellstead G, et al. Systematic review of therapeutic nipple- sparing versus skin-sparing mastectomy. BJS Open. 2019;3:135–45.
doi: 10.1002/bjs5.50119 pubmed: 30957059
Jensen JA, Lin JH, Kapoor N, Giuliano AE. Surgical delay of the nipple-areolar complex: a powerful technique to maximize nipple viability following nipple-sparing mastectomy. Ann Surg Oncol. 2012;19(10):3171–6. https://doi.org/10.1245/s10434-012-2528-7 .
doi: 10.1245/s10434-012-2528-7 pubmed: 22829005
Moo TA, Nelson JA, Sevilimedu V, Charyn J, Le TV, Allen RJ, et al. Strategies to avoid mastectomy skin-flap necrosis during nipple-sparing mastectomy. Br J Surg. 2023;110(7):831–8. https://doi.org/10.1093/bjs/znad107 .
doi: 10.1093/bjs/znad107 pubmed: 37178195 pmcid: 10517092
Colwell AS, Tessler O, Lin AM, Liao E, Winograd J, Cetrulo CL, et al. Breast reconstruction following nipple-sparing mastectomy: predictors of complications, reconstruction outcomes, and 5-year trends. Plast Reconstr Surg. 2014;133:496–506.
doi: 10.1097/01.prs.0000438056.67375.75 pubmed: 24572843
Martinez CA, Reis SM, Sato EA, et al. The nipple-areola preserving mastectomy: a multistage procedure aiming to improve reconstructive outcomes following mastectomy. Plast Reconstr Surg Glob Open. 2015;3:e538.
doi: 10.1097/GOX.0000000000000516 pubmed: 26579344 pmcid: 4634175
Palmieri B, Baitchev G, Grappolini S, et al. Delayed nipple sparing modified subcutaneous mastectomy: rationale and technique. Breast J. 2005;11:173–8.
doi: 10.1111/j.1075-122X.2005.21520.x pubmed: 15871701
Lee PL, Ma IT, Schusterman MA, Beiriger J, Ahrendt G, De La Cruz C, et al. Surgical nipple delay and its expanded indications for nipple-sparing mastectomy. Plast Reconstr Surg Global Open. 2023;11(1):e4783.
doi: 10.1097/GOX.0000000000004783
Bertoni DM, Nguyen D, Rochlin D, et al. Protecting nipple perfusion by devascularization and surgical delay in patients at risk for ischemic complications during nipple-sparing mastectomies. Ann Surg Oncol. 2016;23:2665–72.
doi: 10.1245/s10434-016-5201-8 pubmed: 27038458
Rochlin D, Ngyuen DH. Deepithelialized skin reduction preserves skin and nipple perfusion in immediate reconstruction of large and ptotic breasts. Ann Plast Surg. 2018;81(1):22–7.
doi: 10.1097/SAP.0000000000001427 pubmed: 29746276
Lee KT, Pyon J, Bang S, et al. Does the reconstruction method influence development of mastectomy flap complications in nipple-sparing mastectomy? J Plast Reconstr Aesthet Surg. 2013;66:1543–50.
doi: 10.1016/j.bjps.2013.06.032 pubmed: 23834909
Bykowski MR, Emelife PI, Emelife NN, et al. Nipple-areola complex reconstruction improves psychosocial and sexual well-being in women treated for breast cancer. J Plast Reconstr Aesthet Surg. 2017;70:209–14.
doi: 10.1016/j.bjps.2016.10.009 pubmed: 27988150
Ito H, Ueno T, Suga H, et al. Risk factors for skin flap necrosis in breast cancer patients treated with mastectomy followed by immediate breast reconstruction. World J Surg. 2019;43:846–52.
doi: 10.1007/s00268-018-4852-y pubmed: 30426185

Auteurs

Xuanji Wang (X)

Cedars-Sinai Medical Center, Los Angeles, CA, USA. xuwang12@gmail.com.

Jordan Jackson (J)

Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Christina Weed (C)

Franciscan Breast Surgery at St. Michael, Silverdale, WA, USA.

Marissa K Boyle (MK)

Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Farin F Amersi (FF)

Cedars-Sinai Medical Center, Los Angeles, CA, USA.

James Mirocha (J)

Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Armando E Giuliano (AE)

Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Alice P Chung (AP)

Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Classifications MeSH